Physician profile
Rebekah E Booth
NPI 1194997502
$1,096.53
in general payments reported to CMS, 2019-2025
13 companies · $297 in 2025
The $297 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.34 · 2021: $58.60 · 2022: $103 · 2023: $277 · 2024: $322 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $483.30 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $147.45 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $87.59 | 2022-2025 | Bexsero, Pediarix, Rotarix |
| Tris Pharma INC | $87.26 | 2022-2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $80.05 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $53.33 | 2021-2024 | Qelbree |
| Sobi, INC | $45.10 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.58 | 2021-2023 | |
| Biomarin Pharmaceutical INC. | $25.43 | 2024 | Voxzogo 1.2mg |
| Abbott Laboratories | $14.33 | 2023 | Id Now Instrument |
| Sanofi Pasteur INC. | $13.48 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.97 | 2019 | |
| Pfizer INC. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebekah Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.